Drug profile · INN
cefuroxime sodium
CEFUROXIME SODIUM
cefuroxime sodium (CEFUROXIME SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefuroxime sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
cefuroxime sodium (CEFUROXIME SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is cefuroxime sodium?
cefuroxime sodium (CEFUROXIME SODIUM) is a bacterial penicillin-binding protein inhibitor. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefuroxime sodium?
CEFUROXIME SODIUM is a marketed brand name for cefuroxime sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefuroxime sodium?
cefuroxime sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.